EML4 and non-small cell lung carcinoma: About 3–5% of non small cell lung cancer (NSCLC) harbor Anaplastic lymphoma kinase (ALK)-rearrangement, mainly with echinoderm microtubule-associated protein-like 4 (EML4) as a gene partner.